This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bhandari, N. Articles by Bhan, M. K. Search for Related Content PubMed PubMed Citation Articles by Bhandari, N. Articles by Bhan, M. K. Social Bookmarking                         What's this?

PEDIATRICS Vol. 109 No. 6 June 2002, pp. e86

ELECTRONIC ARTICLE

Substantial Reduction in Severe Diarrheal Morbidity by Daily Zinc Supplementation in Young North Indian Children

Nita Bhandari, PhD^*, Rajiv Bahl, PhD^*, Sunita Taneja, MD^*, Tor Strand, MD, Kåre Mølbak, MD, Rune Johan Ulvik, PhD^||, Halvor Sommerfelt, PhD and Maharaj K. Bhan, MD^*

^* Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
Center for International Health, University of Bergen, Norway
Statens Serum Institut, Copenhagen, Denmark
^|| Institute of Clinical Biochemistry, University of Bergen, Bergen, Norway

--> Objective. To evaluate the impact of 4 months of daily zinc supplementation on the incidence of severe and recurrent diarrhea in children 6 to 30 months of age.

Methods. A double-blind, randomized, placebo-controlled trial was conducted on children who were identified by a door-to-door survey to be aged 6 to 30 months and residing in the urban slum of Dakshinpuri, New Delhi. They were randomized to receive daily zinc gluconate (elemental zinc 10 mg to infants and 20 mg to older children) or placebo. A field attendant administered the syrup daily at home for 4 months except on Sundays, when the mother did so. One bottle that contained 250 mL was kept in the child’s home and replaced monthly. Field workers visited households every seventh day during the 4-month follow-up period. At each visit, information was obtained for the previous 7 days on history of fever, number and consistency of stools, and presence of cough. When the child was ill, illness characteristics and treatment seeking outside the home were determined. If the child had diarrhea or vomiting, then dehydration was assessed. At household visits, 2 packets of oral rehydration salts were given when a child had diarrhea. Children who visited the study clinic spontaneously for illness or were referred by the field workers were treated according to the standard national program guidelines. Antibiotics were advised only for diarrhea with bloody stools or for associated illnesses. For using generalized estimating equations for longitudinal analysis of a recurring event such as diarrhea, the follow-up data for each child was divided into 17 child-periods of 7 days each and presence or absence of an incident episode of diarrhea or severe diarrhea within each 7-day period was coded. This method of analysis does not assume independence of events and therefore prevents underestimation of variance that results because of correlation of morbidity within the same child. A logistic generalized estimating equations model with exchangeable correlation covariance-variance matrix was then used to estimate the effect size.

Results. Zinc or placebo doses were administered on 88.8% and 91.2%, respectively, of study days during the 4 months of follow-up. There was a small but significant increase in the average number of days with vomiting in the zinc group (4.3 [standard deviation (SD): 5.8] vs 2.6 [SD 3.9] days; difference in means: 1.7 [95% confidence interval (CI): 1.3–2.1] days). At the baseline, mean plasma zinc was 62.0 µg/dL (SD: 14.3 µg/dL) in the zinc and 62.0 µg/dL (SD: 11.2 µ g/dL) in the placebo group; 45.8% and 42%, respectively, had low plasma zinc levels below 60 µg/dL. At the end of the study, plasma zinc levels were substantially higher in the zinc group (ratio of geometric means: 1.94 [95% CI: 1.86–2.03]) and the proportion with low plasma zinc was lower (difference in proportions: -46.7% [95% CI: -41.8% to -51.4%]). The incidence of diarrhea during follow-up was lower in the zinc-supplemented as compared with the placebo group (odds ratio [OR]: 0.88; 95% CI: 0.82–0.95). The beneficial impact of zinc was greater on the incidence of diarrhea with progressively increasing duration: episodes of diarrhea that lasted 1 to 6 days (OR: 0.92; 95% CI: 0.85–1.00), 7 to 13 days (OR: 0.79; 95% CI: 0.65–0.95), and 14 days (OR: 0.69; 95% CI: 0.48–0.98). The impact was also greater on the incidence of episodes with progressively higher stool frequency: 3 to 5 stools per day (OR: 0.90; 95% CI: 0.83–0.98), 6 to 9 stools per day (OR: 0.87; 95% CI: 0.77–0.98), and 10 per day (OR: 0.77; 95% CI: 0.63–0.94). In the zinc group, significantly more children experienced no diarrheal episode during the study period (risk ratio [RR]: 1.22; 95% CI: 1.02–1.44). Furthermore, substantially fewer children (RR: 0.51; 95% CI: 0.36–0.73) experienced recurrent diarrhea, defined as >6 diarrheal episodes in the follow-up period as compared with children in the placebo group. The number of children who were hospitalized for any cause tended to be lower in the zinc group, but the difference was not statistically significant (1.79% vs 2.43%; RR: 0.74; 95% CI: 0.43–1.27). The baseline mean plasma copper (µg/dL) was similar in the 2 groups (difference in means: 1.6; 95% CI: -2.9 to 6.1). The end study plasma copper levels were significantly lower in the zinc group (difference in means: -15.5; 95% CI: -19.9 to - 11.1).

Conclusions. Zinc supplementation substantially reduced the incidence of severe and prolonged diarrhea, the 2 important determinants of diarrhea-related mortality and malnutrition. This intervention also substantially reduced the proportion of children who experienced recurrent diarrhea. Prompt measures to improve zinc status of deficient populations are warranted. The potential approaches to achieve this goal include food fortification, dietary diversification, cultivation of plants that are zinc dense or have a decreased concentration of zinc absorption inhibitors, and supplementation of selected groups of children. Future studies should assess the impact of increased zinc intakes on childhood mortality in developing countries. For facilitating intervention, there is a need to obtain reliable estimates of zinc deficiency, particularly in developing countries. The functional consequences of the effect of various doses of zinc on plasma copper levels merits additional study.

Key Words: zinc supplementation • diarrhea • severe diarrhea • recurrent diarrhea • copper status

Abbreviations: GEE, generalized estimating equations • CI, confidence interval • SD, standard deviation • OR, odds ratio • RR, risk ratio

---

Received for publication Nov 27, 2001; Accepted Feb 13, 2002.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. E Wuehler, F. Sempertegui, and K. H Brown Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency Am. J. Clinical Nutrition, March 1, 2008; 87(3): 723 - 733. [Abstract] [Full Text] [PDF]

				J. K. Crane, T. M. Naeher, I. Shulgina, C. Zhu, and E. C. Boedeker Effect of Zinc in Enteropathogenic Escherichia coli Infection Infect. Immun., December 1, 2007; 75(12): 5974 - 5984. [Abstract] [Full Text] [PDF]

				C. G. Neumann Background J. Nutr., April 1, 2007; 137(4): 1091 - 1092. [Full Text] [PDF]

				C. L F. Walker, Z. A Bhutta, N. Bhandari, T. Teka, F. Shahid, S. Taneja, R. E Black, and the Zinc Study Group Zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants <6 mo of age Am. J. Clinical Nutrition, March 1, 2007; 85(3): 887 - 894. [Abstract] [Full Text] [PDF]

				K. Z Long, Y. Montoya, E. Hertzmark, J. I Santos, and J. L Rosado A double-blind, randomized, clinical trial of the effect of vitamin A and zinc supplementation on diarrheal disease and respiratory tract infections in children in Mexico City, Mexico Am. J. Clinical Nutrition, March 1, 2006; 83(3): 693 - 700. [Abstract] [Full Text] [PDF]

				R. Shamir, I. R. Makhoul, A. Etzioni, and N. Shehadeh Evaluation of a Diet Containing Probiotics and Zinc for the Treatment of Mild Diarrheal Illness in Children Younger Than One Year of Age J. Am. Coll. Nutr., October 1, 2005; 24(5): 370 - 375. [Abstract] [Full Text] [PDF]

				F. Qadri, A.-M. Svennerholm, A. S. G. Faruque, and R. B. Sack Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention Clin. Microbiol. Rev., July 1, 2005; 18(3): 465 - 483. [Abstract] [Full Text] [PDF]

				T. H. Karlsen, H. Sommerfelt, S. Klomstad, P. K. Andersen, T. A. Strand, R. J. Ulvik, C. Ahren, and H. M. S. Grewal Intestinal and Systemic Immune Responses to an Oral Cholera Toxoid B Subunit Whole-Cell Vaccine Administered during Zinc Supplementation Infect. Immun., July 1, 2003; 71(7): 3909 - 3913. [Abstract] [Full Text] [PDF]

				P. A. Alarcon, L.-H. Lin, M. Noche Jr, V. C. Hernandez, L. Cimafranca, W. Lam, and G. M. Comer Effect of Oral Supplementation on Catch-Up Growth in Picky Eaters Clinical Pediatrics, April 1, 2003; 42(3): 209 - 217. [Abstract] [PDF]